Compare AVXL & FVCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVXL | FVCB |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 289.1M | 267.9M |
| IPO Year | 2013 | 2018 |
| Metric | AVXL | FVCB |
|---|---|---|
| Price | $3.40 | $15.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $22.00 | $18.00 |
| AVG Volume (30 Days) | ★ 2.0M | 84.5K |
| Earning Date | 05-12-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | N/A | ★ 47.56 |
| EPS | N/A | ★ 1.21 |
| Revenue | N/A | ★ $1,781,000.00 |
| Revenue This Year | N/A | $13.83 |
| Revenue Next Year | N/A | $7.45 |
| P/E Ratio | ★ N/A | $12.74 |
| Revenue Growth | N/A | ★ 13.87 |
| 52 Week Low | $2.61 | $9.79 |
| 52 Week High | $13.99 | $16.35 |
| Indicator | AVXL | FVCB |
|---|---|---|
| Relative Strength Index (RSI) | 47.74 | 54.65 |
| Support Level | $2.93 | $12.05 |
| Resistance Level | $4.88 | $15.40 |
| Average True Range (ATR) | 0.18 | 0.35 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 98.62 | 47.00 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.